DexCom, Inc. (DXCM)
NASDAQ: DXCM · Real-Time Price · USD
80.27
-1.35 (-1.65%)
At close: May 5, 2025, 4:00 PM
80.00
-0.27 (-0.34%)
Pre-market: May 6, 2025, 4:22 AM EDT
DexCom Stock Forecast
Stock Price Forecast
The 18 analysts with 12-month price forecasts for DexCom stock have an average target of 98.11, with a low estimate of 82 and a high estimate of 120. The average target predicts an increase of 22.22% from the current stock price of 80.27.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for DexCom stock from 18 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 7 | 7 | 7 | 7 |
| Buy | 6 | 7 | 7 | 7 | 8 | 8 |
| Hold | 5 | 4 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 17 | 17 | 17 | 17 | 18 | 18 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Hold Maintains $90 → $93 | Hold | Maintains | $90 → $93 | +15.86% | May 5, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $103 → $106 | Strong Buy | Maintains | $103 → $106 | +32.05% | May 2, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $100 → $90 | Buy | Maintains | $100 → $90 | +12.12% | May 2, 2025 |
| Baird | Baird | Buy Maintains $115 → $105 | Buy | Maintains | $115 → $105 | +30.81% | May 2, 2025 |
| Mizuho | Mizuho | Buy Initiates $85 | Buy | Initiates | $85 | +5.89% | Apr 10, 2025 |
Financial Forecast
Revenue This Year
4.70B
from 4.03B
Increased by 16.49%
Revenue Next Year
5.42B
from 4.70B
Increased by 15.45%
EPS This Year
2.06
from 1.42
Increased by 44.65%
EPS Next Year
2.53
from 2.06
Increased by 22.73%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 4.9B | 5.8B | 6.9B | ||
| Avg | 4.7B | 5.4B | 6.2B | ||
| Low | 4.5B | 5.1B | 5.6B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 21.4% | 24.5% | 26.8% | ||
| Avg | 16.5% | 15.5% | 15.2% | ||
| Low | 11.2% | 7.8% | 2.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2.23 | 2.88 | 3.64 | ||
| Avg | 2.06 | 2.53 | 3.10 | ||
| Low | 1.92 | 2.24 | 2.55 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 56.3% | 39.7% | 44.1% | ||
| Avg | 44.6% | 22.7% | 22.6% | ||
| Low | 34.9% | 9.0% | 0.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.